Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Energy, banking find favour today
Fri, 19 Jun Closing

The Indian equity markets gained further ground during the previous two hours of trade, ending the day on a firm note. While the BSE-Sensex today higher by about 200 points, the NSE-Nifty closed higher by 66 points. Midcap and smallcap stocks too closed in the green today. While the BSE Mid Cap index was up by 0.6% the BSE Small Cap index closed higher by 0.3%. Oil & Gas and Banking stocks were the biggest gainers today.

With regards to international cues, Asian markets finished mixed as of the most recent closing prices. The Nikkei 225 gained 0.92% and the Hang Seng rose 0.20%. The Shanghai Composite lost 6.42%. European shares were seen opening higher buoyed by a rally on Wall Street overnight. The rupee was trading at 63.84 against the US$.

Stocks in the Healthcare sector ended the trading day on a firm note. Divis Laboratories and IPCA Labs were the leading gainers. According to a leading financial daily, drug firm Dr Reddy's Laboratories has completed the acquisition of select portfolio of established brands of Belgian firm UCB in India. The company has reportedly acquired selected portfolios of established brands of UCB in India, Nepal, Sri Lanka and Maldives for Rs 8 bn. The company had also entered into a definitive agreement with UCB which also entails absorbing 350 employees engaged in the operations of India business. Dr Reddy's Laboratories ended the trading day on a firm note.

Shares of Larsen and Toubro (L&T) gained 1.6% Friday after its construction subsidiary won orders worth Rs 22.78 bn in May and June. Its power transmission and distribution segment received orders worth Rs 12.5 bn in international markets and Rs 10.2 bn worth of orders were won by its heavy civil infrastructure segment. Subsidiary L&T Saudi Arabia LLC bagged a contract from National Grid Saudi Arabia for engineering, procurement and construction of 132 KV cabling work in Hail city and a 132 KV double circuit transmission line in Turaif, Qaseem and Hail areas of Saudi Arabia. Another subsidiary L&T Oman LLC received an order from Oman Electricity Transmission Company. Also the company received a major order from a Government agency to design and build 66 kV substations with associated cabling works in the GCC market.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Energy, banking find favour today". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.